MCID: CRN017
MIFTS: 47

Coronary Thrombosis

Categories: Cardiovascular diseases, Blood diseases

Aliases & Classifications for Coronary Thrombosis

MalaCards integrated aliases for Coronary Thrombosis:

Name: Coronary Thrombosis 12 52 42 14 69
Coronary Artery Thrombosis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:11847
ICD10 33 I21 I22
MeSH 42 D003328
UMLS 69 C0010072

Summaries for Coronary Thrombosis

MalaCards based summary : Coronary Thrombosis, also known as coronary artery thrombosis, is related to essential thrombocythemia and angina pectoris. An important gene associated with Coronary Thrombosis is PLAT (Plasminogen Activator, Tissue Type), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and ECM-receptor interaction. The drugs Aspirin and Abciximab have been mentioned in the context of this disorder. Affiliated tissues include heart, testes and endothelial, and related phenotypes are hematopoietic system and cardiovascular system

Wikipedia : 72 Coronary thrombosis is the formation of a blood clot inside a blood vessel of the heart. This blood clot... more...

Related Diseases for Coronary Thrombosis

Diseases related to Coronary Thrombosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 162)
id Related Disease Score Top Affiliating Genes
1 essential thrombocythemia 27.8 F3 GP1BA ITGB3 SERPINC1 VWF
2 angina pectoris 27.3 F3 PLAT SERPINC1 SERPINE1 VWF
3 myocardial infarction 26.9 F3 GP1BA ITGB3 P2RY12 PLAT SERPINC1
4 thrombosis 10.9
5 egg allergy 10.6 PLAT SERPINC1
6 conjunctival disease 10.6 PLAT SERPINC1
7 superior limbic keratoconjunctivitis 10.6 ITGB3 SERPINC1
8 inferior myocardial infarction 10.6 PLAT SERPINC1
9 cerebral cavernous malformations 3 10.6 PLAT SERPINC1
10 fetal hydantoin syndrome 10.6 GP1BA ITGB3
11 third branchial cleft anomaly 10.6 GP1BA ITGB3
12 dyskeratosis congenita autosomal recessive 10.5 PLAT SERPINC1
13 elizabethkingia anophelis infection 10.4 PLAT VWF
14 hepatocellular adenoma 10.4 GP1BA ITGB3
15 alpha-2-plasmin inhibitor deficiency 10.4 GP1BA VWF
16 ube2t-related fanconi anemia 10.4 GP1BA VWF
17 acro-pectoro-renal field defect 10.4 GP1BA VWF
18 split-hand/foot malformation 1 with sensorineural hearing loss 10.4 PLAT SERPINE1
19 congenital leptin deficiency 10.4 ITGB3 P2RY12
20 thrombocytopenic purpura, autoimmune 10.4 GP1BA ITGB3
21 cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorinural hearing loss 10.4 PLAT SERPINE1
22 autonomic peripheral neuropathy 10.4 ITGB3 VWF
23 angular blepharoconjunctivitis 10.3 SERPINC1 SERPINF1
24 hypopharynx cancer 10.3 PLAT SERPINE1
25 collagenous colitis 10.3 SERPINC1 SERPINE1
26 barbiturate abuse 10.3 PLAT SERPINE1
27 inferolateral myocardial infarct 10.3 SERPINC1 SERPINE1
28 rheumatoid lung disease 10.3 SERPINC1 SERPINE1
29 bernard-soulier syndrome, type a2 10.3 GP1BA SERPINC1
30 mental retardation dysmorphism hypogonadism diabetes 10.3 SERPINC1 SERPINE1
31 neuroaxonal dystrophy 10.3 SERPINC1 SERPINE1
32 joint disorders 10.2 GP1BA ITGB3 SERPINC1
33 stickler sydrome, type i, nonsyndromic ocular 10.2 SERPINC1 SERPINE1
34 oppositional defiant disorder 10.2 PLAT SERPINE1
35 acute myocardial infarction 10.2
36 dysgammaglobulinemia 10.2 SERPINC1 SERPINE1
37 cataract, autosomal dominant congenital 4 10.2 SERPINE1 VWF
38 sagittal sinus thrombosis 10.1 F3 SERPINC1
39 pyridoxine deficiency anemia 10.1 F3 SERPINC1
40 fragile x syndrome type 2 10.1 F3 SERPINC1
41 hereditary amyloidosis 10.1 F3 SERPINC1
42 myiasis 10.1 F3 SERPINC1
43 testicular gonadoblastoma 10.1 F3 SERPINC1
44 rectum neuroendocrine neoplasm 10.1 F3 SERPINC1
45 retromolar area cancer 10.1 GP1BA ITGB3 VWF
46 lethal congenital contracture syndrome 10.1 F3 SERPINC1
47 spinal cord lipoma 10.1 F3 SERPINC1
48 immunodeficiency 21 10.1 GP1BA ITGB3 VWF
49 angioedema, hereditary, type iii 10.1 F3 SERPINC1
50 congenital syphilis 10.1 F3 SERPINC1

Graphical network of the top 20 diseases related to Coronary Thrombosis:



Diseases related to Coronary Thrombosis

Symptoms & Phenotypes for Coronary Thrombosis

MGI Mouse Phenotypes related to Coronary Thrombosis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.91 PLAT SERPINC1 SERPINE1 SERPINF1 VWF F3
2 cardiovascular system MP:0005385 9.87 F3 ITGB3 PLAT SERPINC1 SERPINE1 SERPINF1
3 homeostasis/metabolism MP:0005376 9.76 F3 GP1BA ITGB3 P2RY12 PLAT SERPINC1
4 immune system MP:0005387 9.5 F3 ITGB3 PLAT SERPINC1 SERPINE1 SERPINF1
5 vision/eye MP:0005391 9.02 ITGB3 PLAT SERPINC1 SERPINF1 F3

Drugs & Therapeutics for Coronary Thrombosis

Drugs for Coronary Thrombosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 454)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
2
Abciximab Approved Phase 4,Phase 3,Phase 2 143653-53-6
3
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
4
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
5
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
6
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2 9005-49-6 772 46507594
7
Nicorandil Approved Phase 4 65141-46-0 47528
8
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 274693-27-5 9871419
9
Salicylic acid Approved, Vet_approved Phase 4,Phase 2 69-72-7 338
10
Warfarin Approved Phase 4,Phase 3,Phase 2,Phase 1 81-81-2 6691 54678486
11
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
12
Tirofiban Approved Phase 4,Phase 3 144494-65-5 60947
13
Chromium Approved Phase 4,Phase 2,Phase 3 7440-47-3 27668
14
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2 33069-62-4 36314
15
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2 128270-60-0 16129704
16
Tenecteplase Approved Phase 4,Phase 2,Phase 1 191588-94-0
17
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 73590-58-6 4594
18
Pantoprazole Approved Phase 4,Phase 3,Phase 1 102625-70-7 4679
19
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3 55-56-1 9552079 2713
20
Phenprocoumon Approved Phase 4,Phase 2 435-97-2 9908 54680692
21
Acenocoumarol Approved Phase 4,Phase 3 152-72-7 9052 54676537
22
Rivaroxaban Approved Phase 4,Phase 3,Phase 2 366789-02-8
23
Coal tar Approved Phase 4 8007-45-2
24
Thrombin Approved Phase 4,Phase 2,Phase 3
25
Eptifibatide Approved, Investigational Phase 4,Phase 3,Phase 2 188627-80-7 123610
26
Nitric Oxide Approved Phase 4,Phase 2,Phase 3,Phase 1 10102-43-9 145068
27
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
28
Ezetimibe Approved Phase 4 163222-33-1 150311
29
Simvastatin Approved Phase 4 79902-63-9 54454
30 Edoxaban Approved Phase 4,Phase 3 480449-70-5
31
Dalteparin Approved Phase 4,Phase 3,Phase 2 9005-49-6
32
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2 58-61-7 60961
33
Metformin Approved Phase 4,Phase 1 657-24-9 14219 4091
34
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
35
Pravastatin Approved Phase 4 81093-37-0 54687
36
Cilostazol Approved Phase 4 73963-72-1 2754
37
Probucol Approved Phase 4 23288-49-5 4912
38
Fenofibrate Approved Phase 4 49562-28-9 3339
39
Streptokinase Approved Phase 4,Phase 3 9002-01-1
40
Pitavastatin Approved Phase 4 147511-69-1, 147526-32-7 6366718 5282452
41
Diltiazem Approved Phase 4 42399-41-7 39186
42
Acetaminophen Approved Phase 4 103-90-2 1983
43
Indomethacin Approved, Investigational Phase 4 53-86-1 3715
44
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
45 Racepinephrine Approved Phase 4
46
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
47
Reteplase Approved Phase 4,Phase 2,Phase 1 133652-38-7 65820
48
Apixaban Approved Phase 4,Phase 3,Phase 2,Phase 1 503612-47-3 10182969
49
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
50
Abacavir Approved, Investigational Phase 4 136470-78-5 65140 441300

Interventional clinical trials:

(show top 50) (show all 1441)

id Name Status NCT ID Phase Drugs
1 Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) Unknown status NCT00963781 Phase 4 Reduced duration (6 months) DAPT
2 Monitoring Response to Antiplatelet Therapy Unknown status NCT00327041 Phase 4
3 Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study Unknown status NCT01013038 Phase 4
4 Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction Unknown status NCT01156662 Phase 4
5 Late Incomplete Stent Apposition Evaluation II: Comparison Between Polimer-based and No-polimer Stent System. IVUS Based Study Unknown status NCT01375855 Phase 4
6 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab Unknown status NCT01383785 Phase 4
7 Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI Unknown status NCT01781715 Phase 4
8 Hormones Inflammation and Thrombosis Unknown status NCT01875185 Phase 4 Aspirin 81 mg PO daily x 7 days
9 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4 Nicorandil;normal saline
10 Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents Unknown status NCT01268371 Phase 4
11 Rosuvastatin for Preventing Deep Vein Thrombosis Unknown status NCT01021488 Phase 4 Rosuvastatin 20mg/d for 14days;enoxaparin only
12 DEDICA (Dose of HEparin During Coronary Angioplasty) Trial Unknown status NCT01694459 Phase 4 Low-dose heparin;Standard dose heparin
13 Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease Unknown status NCT01418794 Phase 4
14 Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis Unknown status NCT02022527 Phase 4 Acetyl Salicylic Acid;Warfarin;Placebo (for Aspirin)
15 Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome Unknown status NCT01951001 Phase 4 Prasugrel
16 Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study. Unknown status NCT01914055 Phase 4
17 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Unknown status NCT00698607 Phase 4 6-month clopidogrel therapy;12-month clopidogrel therapy
18 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry) Unknown status NCT01605721 Phase 4
19 Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease Unknown status NCT02294994 Phase 4 tirofiban
20 Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users Unknown status NCT01063426 Phase 4 High dose Atorvastatin+enoxaparin;Enoxaparin
21 Safety and Effectiveness of the Coronary Momo Stent Unknown status NCT01535625 Phase 4
22 Intimal Hyperplasia Evaluated by Optical Coherence Tomography (OCT) in de Novo Coronary Lesions Treated by Drug-eluting Balloon and Bare-metal Stent Unknown status NCT01057563 Phase 4
23 Assessment of Surface Coverage of Two Types of DES in Diabetes Mellitus and Non- Diabetes Mellitus Unknown status NCT01023919 Phase 4
24 Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial Unknown status NCT01979744 Phase 4
25 Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty Unknown status NCT02592694 Phase 4 cocktail
26 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4 omeprazole;Pantoprazole
27 A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions Unknown status NCT00825773 Phase 4
28 Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation Unknown status NCT00776633 Phase 4 aspirin;clopidogrel;oral anticoagulation
29 Anticoagulation in Stent Intervention Unknown status NCT01141153 Phase 4 Acetylsalicylic Acid + clopidogrel + acenocoumarol;Acetylsalicylic Acid + clopidogrel
30 A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Unknown status NCT01942070 Phase 4
31 EvaluAtion of Predictive Value of Multisite Intracardiac EchoCardiography During Imaging of Structure and funCTION of Left Atrial Appendage in Comparison to Transesophageal Echocardiography Unknown status NCT01371279 Phase 4
32 Do Cobalt Chrome Stent and Paclitaxel-Eluting Stent Have Equivalent Clinical Result in Non-Complex Lesion? Unknown status NCT00852215 Phase 4
33 Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis Unknown status NCT02402491 Phase 4 12 months of P2Y12 receptor antagonist;24 months of P2Y12 receptor antagonist;Aspirin
34 Paradigm Shift in the Treatment of Patients With ACS Unknown status NCT02041650 Phase 4 Ticagrelor
35 Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT Unknown status NCT01021930 Phase 4
36 Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Unknown status NCT02334254 Phase 4 rivaroxaban and ticagrel therapy;triple antithrombotic regimen with warfarin, asipirin and clopidogrel
37 COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent Unknown status NCT00920283 Phase 4
38 Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions Unknown status NCT01278186 Phase 4
39 MGuard Stent in ST-elevation Myocardial Infarction Unknown status NCT01124942 Phase 4
40 A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment Unknown status NCT01880879 Phase 4
41 Local Thrombolytics Before Thrombectomy in STEMI Unknown status NCT01568931 Phase 4 Urokinase;Saline
42 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Unknown status NCT02004730 Phase 4
43 Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting Unknown status NCT00661206 Phase 4 Clopidogrel;Placebo
44 Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor Unknown status NCT01869309 Phase 4 Prasugrel;Ticagrelor
45 The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients Unknown status NCT01510509 Phase 4
46 Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI Unknown status NCT00476944 Phase 4
47 Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI Unknown status NCT02012140 Phase 4 ticagrelor
48 Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients Unknown status NCT01198379 Phase 4 aspirin;Placebo
49 Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction Unknown status NCT00976092 Phase 4 Prasugrel;Bivalirudin;Clopidogrel;Heparin
50 Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery Unknown status NCT01648712 Phase 4

Search NIH Clinical Center for Coronary Thrombosis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: coronary thrombosis

Genetic Tests for Coronary Thrombosis

Anatomical Context for Coronary Thrombosis

MalaCards organs/tissues related to Coronary Thrombosis:

39
Heart, Testes, Endothelial, Kidney, Lung, Whole Blood, Myeloid

Publications for Coronary Thrombosis

Articles related to Coronary Thrombosis:

(show top 50) (show all 521)
id Title Authors Year
1
Tissue plasminogen activator for neonatal coronary thrombosis presenting with mitral valve regurgitation and impaired ventricular function. ( 28140523 )
2017
2
Therapeutic application of contrast ultrasound in ST elevation myocardial infarction: Role in coronary thrombosis and microvascular obstruction. ( 28868906 )
2017
3
Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. ( 28867009 )
2017
4
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. ( 27079334 )
2016
5
Multiple coronary thrombosis. ( 27489604 )
2016
6
A rare cause of acute coronary syndrome: Coronary thrombosis in three coronary arteries due to whey protein. ( 27839839 )
2016
7
Early Post-Operative Coronary Thrombosis Following Repair of a Proximal Coronary Artery Fistula. ( 28208917 )
2016
8
Translation from the data of clinical trials to precision medicine: limitation of the current risk score for predicting coronary thrombosis and major bleeding. ( 27746980 )
2016
9
Coronary Thrombosis without Dissection following Blunt Trauma. ( 27006836 )
2016
10
Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift? ( 27543999 )
2016
11
Multifocal coronary thrombosis on nondisrupted plaque: observation with optical coherence tomography. ( 27159264 )
2016
12
Early Coronary Thrombosis without ST-Segment Elevation Following Repair of Acute Aortic Dissection. ( 28097197 )
2016
13
Endothelial erosion of plaques as a substrate for coronary thrombosis. ( 26791872 )
2016
14
Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature. ( 26607055 )
2016
15
Coronary thrombosis in diabetes: Are we doing enough? ( 27555606 )
2016
16
Acute Myocardial Infarction in a Neonate Caused by a Coronary Thrombosis: a Considerable Diagnostic and Therapeutic Challenge. ( 26297178 )
2015
17
Evading the fate of Pheidippides: acute coronary thrombosis in a young marathon runner with minimal atherosclerosis but sickle cell trait. ( 26331117 )
2015
18
Coronary Thrombosis and Type A Aortic Dissection. ( 25980980 )
2015
19
Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment. ( 26761372 )
2015
20
Simultaneous multi-vessel coronary thrombosis in patients with ST-elevation myocardial infarction: a systematic review. ( 25772369 )
2015
21
Multiple and Contemporary Coronary Thrombosis inspite of Low Platelet Function Response. ( 25302230 )
2014
22
Low-Dose Antithrombotic Treatment in Coronary Thrombosis of Kawasaki Disease. ( 25298222 )
2014
23
Acute ST Elevated Myocardial Injury due to Coronary Thrombosis during Thoracic Endovascular Aortic Repair in Patient with Protein S Deficiency. ( 25469146 )
2014
24
Acute myocardial infarction due to coronary thrombosis caused by blunt chest trauma. ( 24769662 )
2014
25
Acute coronary thrombosis and multiple coronary aneurysms in a 22-year-old man with the human immunodeficiency virus. ( 24808786 )
2014
26
Antithrombotic effect of Z4A5 on coronary thrombosis in a canine model of acute unstable angina. ( 23083032 )
2013
27
Simultaneous double coronary thrombosis in a 47-year-old male patient with acute myocardial infarction. ( 24175009 )
2013
28
Bi-ostial coronary thrombosis due to heparin induced thrombocytopenia. ( 22664366 )
2013
29
Coronary thrombosis from large, nonprotruding, superficial calcified coronary plaques. ( 24080108 )
2013
30
Detection of coronary thrombosis after multi-phase postmortem CT-angiography. ( 22981180 )
2013
31
Mechanisms of coronary thrombosis in cigarette smoke exposure. ( 23685556 )
2013
32
Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis. ( 23460076 )
2013
33
Varenicline-induced coronary thrombosis. ( 24259623 )
2013
34
Proteomic profiling of acute coronary thrombosis reveals a local decrease in pigment epithelium-derived factor in acute myocardial infarction. ( 22315956 )
2012
35
Acute coronary thrombosis after anaphylactic shock treatment. ( 22541413 )
2012
36
Cannabis and coronary thrombosis: What is the role of platelets? ( 21806494 )
2012
37
Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy. ( 22218740 )
2012
38
Myocardial infarction due to coronary thrombosis in a patient with Henoch-SchAPnlein purpura. ( 22361720 )
2012
39
Calcified nodules: an underrated mechanism of coronary thrombosis? ( 23058076 )
2012
40
Does sildenafil contribute to acute coronary thrombosis? ( 23363902 )
2012
41
Diastolic timed Vibro-Percussion at 50 Hz delivered across a chest wall sized meat barrier enhances clot dissolution and remotely administered Streptokinase effectiveness in an in-vitro model of acute coronary thrombosis. ( 23146079 )
2012
42
Multivessel coronary thrombosis in a patient with idiopathic thrombocytopenic purpura. ( 23304046 )
2012
43
Acute coronary thrombosis in Boston marathon runners. ( 22236231 )
2012
44
Coronary thrombosis as the first complication of antiphospholipid syndrome. ( 22735914 )
2012
45
Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study. ( 22684577 )
2012
46
A study to determine chest wall vibratory attachment interface locations for a low frequency sonic vibrator in treatment of acute coronary thrombosis. ( 21547406 )
2011
47
Role of platelet glycoprotein receptor IIIa PI(A2) and traditional risk factors in the etiology of coronary thrombosis. ( 21816456 )
2011
48
Cocaine-induced coronary thrombosis: what is the optimal treatment strategy. ( 21421194 )
2011
49
The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene. ( 21371074 )
2011
50
Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy. ( 21411997 )
2011

Variations for Coronary Thrombosis

Expression for Coronary Thrombosis

Search GEO for disease gene expression data for Coronary Thrombosis.

Pathways for Coronary Thrombosis

Pathways related to Coronary Thrombosis according to GeneCards Suite gene sharing:

(show all 13)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.64 F3 GP1BA ITGB3 P2RY12 PLAT SERPINC1
2
Show member pathways
11.86 GP1BA ITGB3 VWF
3 11.7 F3 PLAT SERPINC1 SERPINE1 VWF
4 11.67 F3 ITGB3 SERPINE1
5 11.65 GP1BA ITGB3 P2RY12 VWF
6
Show member pathways
11.57 GP1BA ITGB3 VWF
7 11.48 F3 ITGB3 VWF
8
Show member pathways
11.31 F3 GP1BA PLAT SERPINC1 SERPINE1 VWF
9 11.21 GP1BA PLAT
10 11.21 ITGB3 P2RY12 VWF
11 10.61 PLAT SERPINE1
12 10.59 GP1BA VWF
13 10.43 GP1BA VWF

GO Terms for Coronary Thrombosis

Cellular components related to Coronary Thrombosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.73 F3 PLAT SERPINC1 SERPINE1 SERPINF1 VWF
2 extracellular exosome GO:0070062 9.56 F3 GP1BA ITGB3 PLAT SERPINC1 SERPINE1
3 cell surface GO:0009986 9.55 F3 GP1BA ITGB3 P2RY12 PLAT
4 extracellular matrix GO:0031012 9.02 F3 PLAT SERPINE1 SERPINF1 VWF

Biological processes related to Coronary Thrombosis according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 extracellular matrix organization GO:0030198 9.69 ITGB3 SERPINE1 VWF
2 negative regulation of endopeptidase activity GO:0010951 9.61 SERPINC1 SERPINE1 SERPINF1
3 platelet degranulation GO:0002576 9.58 ITGB3 SERPINE1 VWF
4 platelet activation GO:0030168 9.56 GP1BA ITGB3 P2RY12 VWF
5 platelet aggregation GO:0070527 9.5 GP1BA ITGB3 P2RY12
6 regulation of blood coagulation GO:0030193 9.49 GP1BA SERPINC1
7 blood coagulation, intrinsic pathway GO:0007597 9.48 GP1BA VWF
8 cell-substrate adhesion GO:0031589 9.46 ITGB3 VWF
9 smooth muscle cell migration GO:0014909 9.37 ITGB3 PLAT
10 hemostasis GO:0007599 9.35 F3 GP1BA P2RY12 SERPINC1 VWF
11 fibrinolysis GO:0042730 9.33 GP1BA PLAT SERPINE1
12 blood coagulation GO:0007596 9.17 F3 GP1BA ITGB3 P2RY12 PLAT SERPINC1

Molecular functions related to Coronary Thrombosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 serine-type endopeptidase inhibitor activity GO:0004867 9.13 SERPINC1 SERPINE1 SERPINF1
2 protease binding GO:0002020 9.02 F3 ITGB3 SERPINC1 SERPINE1 VWF

Sources for Coronary Thrombosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....